The global HCN Derivate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

HCN derivatives are various compounds generated by chemical reactions based on hydrocyanic acid (HCN). These derivatives usually contain a cyano (-CN) group in their chemical structure. Cyano compounds are widely used in many industries due to their diverse reactivity and functionality.

From a downstream perspective, Chemical Industry accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

HCN Derivate leading manufacturers including Invista, Solvay, Evonik, Cyanco, BASF, NOVUS, Orica, Chemours, Sumitomo Chemical, Ascend Performance Materials, etc., dominate supply; the top five capture approximately % of global revenue, with Invista leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global HCN Derivate market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of HCN Derivate Market Report

Report Metric	Details
Report Name	HCN Derivate Market
Segment by Type	Sodium Cyanide Adiponitrile Methionine Others
Segment by Application	Chemical Industry Mining Industry Pharmaceutical Others
Production by Region	North America Europe China Japan
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Invista, Solvay, Evonik, Cyanco, BASF, NOVUS, Orica, Chemours, Sumitomo Chemical, Ascend Performance Materials, Australian Gold Reagent, Taekwang Industrial, Asahi Kasei Corporation, Tiande Chemical, Sichuan Hebang, Hebei Chengxin, Anhui Shuguang Chemical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the HCN Derivate study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the HCN Derivate Market report?

Ans: The main players in the HCN Derivate Market are Invista, Solvay, Evonik, Cyanco, BASF, NOVUS, Orica, Chemours, Sumitomo Chemical, Ascend Performance Materials, Australian Gold Reagent, Taekwang Industrial, Asahi Kasei Corporation, Tiande Chemical, Sichuan Hebang, Hebei Chengxin, Anhui Shuguang Chemical Group

What are the Application segmentation covered in the HCN Derivate Market report?

Ans: The Applications covered in the HCN Derivate Market report are Chemical Industry, Mining Industry, Pharmaceutical, Others

What are the Type segmentation covered in the HCN Derivate Market report?

Ans: The Types covered in the HCN Derivate Market report are Sodium Cyanide, Adiponitrile, Methionine, Others

1 Study Coverage

1.1 Introduction to HCN Derivate: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global HCN Derivate Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Sodium Cyanide

1.2.3 Adiponitrile

1.2.4 Methionine

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global HCN Derivate Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Chemical Industry

1.3.3 Mining Industry

1.3.4 Pharmaceutical

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global HCN Derivate Revenue Estimates and Forecasts 2020-2031

2.2 Global HCN Derivate Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global HCN Derivate Sales Estimates and Forecasts 2020-2031

2.4 Global HCN Derivate Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global HCN Derivate Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global HCN Derivate Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global HCN Derivate Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Sodium Cyanide Market Size by Manufacturers

4.5.2 Adiponitrile Market Size by Manufacturers

4.5.3 Methionine Market Size by Manufacturers

4.5.4 Others Market Size by Manufacturers

4.6 Global HCN Derivate Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global HCN Derivate Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global HCN Derivate Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global HCN Derivate Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global HCN Derivate Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America HCN Derivate Sales and Revenue by Type (2020-2031)

7.4 North America HCN Derivate Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America HCN Derivate Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe HCN Derivate Sales and Revenue by Type (2020-2031)

8.4 Europe HCN Derivate Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe HCN Derivate Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific HCN Derivate Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific HCN Derivate Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific HCN Derivate Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America HCN Derivate Sales and Revenue by Type (2020-2031)

10.4 Central and South America HCN Derivate Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America HCN Derivate Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa HCN Derivate Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa HCN Derivate Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa HCN Derivate Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Invista

12.1.1 Invista Corporation Information

12.1.2 Invista Business Overview

12.1.3 Invista HCN Derivate Product Models, Descriptions and Specifications

12.1.4 Invista HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Invista HCN Derivate Sales by Product in 2024

12.1.6 Invista HCN Derivate Sales by Application in 2024

12.1.7 Invista HCN Derivate Sales by Geographic Area in 2024

12.1.8 Invista HCN Derivate SWOT Analysis

12.1.9 Invista Recent Developments

12.2 Solvay

12.2.1 Solvay Corporation Information

12.2.2 Solvay Business Overview

12.2.3 Solvay HCN Derivate Product Models, Descriptions and Specifications

12.2.4 Solvay HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Solvay HCN Derivate Sales by Product in 2024

12.2.6 Solvay HCN Derivate Sales by Application in 2024

12.2.7 Solvay HCN Derivate Sales by Geographic Area in 2024

12.2.8 Solvay HCN Derivate SWOT Analysis

12.2.9 Solvay Recent Developments

12.3 Evonik

12.3.1 Evonik Corporation Information

12.3.2 Evonik Business Overview

12.3.3 Evonik HCN Derivate Product Models, Descriptions and Specifications

12.3.4 Evonik HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Evonik HCN Derivate Sales by Product in 2024

12.3.6 Evonik HCN Derivate Sales by Application in 2024

12.3.7 Evonik HCN Derivate Sales by Geographic Area in 2024

12.3.8 Evonik HCN Derivate SWOT Analysis

12.3.9 Evonik Recent Developments

12.4 Cyanco

12.4.1 Cyanco Corporation Information

12.4.2 Cyanco Business Overview

12.4.3 Cyanco HCN Derivate Product Models, Descriptions and Specifications

12.4.4 Cyanco HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Cyanco HCN Derivate Sales by Product in 2024

12.4.6 Cyanco HCN Derivate Sales by Application in 2024

12.4.7 Cyanco HCN Derivate Sales by Geographic Area in 2024

12.4.8 Cyanco HCN Derivate SWOT Analysis

12.4.9 Cyanco Recent Developments

12.5 BASF

12.5.1 BASF Corporation Information

12.5.2 BASF Business Overview

12.5.3 BASF HCN Derivate Product Models, Descriptions and Specifications

12.5.4 BASF HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 BASF HCN Derivate Sales by Product in 2024

12.5.6 BASF HCN Derivate Sales by Application in 2024

12.5.7 BASF HCN Derivate Sales by Geographic Area in 2024

12.5.8 BASF HCN Derivate SWOT Analysis

12.5.9 BASF Recent Developments

12.6 NOVUS

12.6.1 NOVUS Corporation Information

12.6.2 NOVUS Business Overview

12.6.3 NOVUS HCN Derivate Product Models, Descriptions and Specifications

12.6.4 NOVUS HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 NOVUS Recent Developments

12.7 Orica

12.7.1 Orica Corporation Information

12.7.2 Orica Business Overview

12.7.3 Orica HCN Derivate Product Models, Descriptions and Specifications

12.7.4 Orica HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Orica Recent Developments

12.8 Chemours

12.8.1 Chemours Corporation Information

12.8.2 Chemours Business Overview

12.8.3 Chemours HCN Derivate Product Models, Descriptions and Specifications

12.8.4 Chemours HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Chemours Recent Developments

12.9 Sumitomo Chemical

12.9.1 Sumitomo Chemical Corporation Information

12.9.2 Sumitomo Chemical Business Overview

12.9.3 Sumitomo Chemical HCN Derivate Product Models, Descriptions and Specifications

12.9.4 Sumitomo Chemical HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Sumitomo Chemical Recent Developments

12.10 Ascend Performance Materials

12.10.1 Ascend Performance Materials Corporation Information

12.10.2 Ascend Performance Materials Business Overview

12.10.3 Ascend Performance Materials HCN Derivate Product Models, Descriptions and Specifications

12.10.4 Ascend Performance Materials HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 Ascend Performance Materials Recent Developments

12.11 Australian Gold Reagent

12.11.1 Australian Gold Reagent Corporation Information

12.11.2 Australian Gold Reagent Business Overview

12.11.3 Australian Gold Reagent HCN Derivate Product Models, Descriptions and Specifications

12.11.4 Australian Gold Reagent HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Australian Gold Reagent Recent Developments

12.12 Taekwang Industrial

12.12.1 Taekwang Industrial Corporation Information

12.12.2 Taekwang Industrial Business Overview

12.12.3 Taekwang Industrial HCN Derivate Product Models, Descriptions and Specifications

12.12.4 Taekwang Industrial HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 Taekwang Industrial Recent Developments

12.13 Asahi Kasei Corporation

12.13.1 Asahi Kasei Corporation Corporation Information

12.13.2 Asahi Kasei Corporation Business Overview

12.13.3 Asahi Kasei Corporation HCN Derivate Product Models, Descriptions and Specifications

12.13.4 Asahi Kasei Corporation HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Asahi Kasei Corporation Recent Developments

12.14 Tiande Chemical

12.14.1 Tiande Chemical Corporation Information

12.14.2 Tiande Chemical Business Overview

12.14.3 Tiande Chemical HCN Derivate Product Models, Descriptions and Specifications

12.14.4 Tiande Chemical HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 Tiande Chemical Recent Developments

12.15 Sichuan Hebang

12.15.1 Sichuan Hebang Corporation Information

12.15.2 Sichuan Hebang Business Overview

12.15.3 Sichuan Hebang HCN Derivate Product Models, Descriptions and Specifications

12.15.4 Sichuan Hebang HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.15.5 Sichuan Hebang Recent Developments

12.16 Hebei Chengxin

12.16.1 Hebei Chengxin Corporation Information

12.16.2 Hebei Chengxin Business Overview

12.16.3 Hebei Chengxin HCN Derivate Product Models, Descriptions and Specifications

12.16.4 Hebei Chengxin HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.16.5 Hebei Chengxin Recent Developments

12.17 Anhui Shuguang Chemical Group

12.17.1 Anhui Shuguang Chemical Group Corporation Information

12.17.2 Anhui Shuguang Chemical Group Business Overview

12.17.3 Anhui Shuguang Chemical Group HCN Derivate Product Models, Descriptions and Specifications

12.17.4 Anhui Shuguang Chemical Group HCN Derivate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.17.5 Anhui Shuguang Chemical Group Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 HCN Derivate Industry Chain

13.2 HCN Derivate Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 HCN Derivate Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 HCN Derivate Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 HCN Derivate Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global HCN Derivate Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

FEATURED COMPANIES

Ascend Performance Materials

Australian Gold Reagent

Taekwang Industrial

Asahi Kasei Corporation

Tiande Chemical

Sichuan Hebang

Hebei Chengxin

Anhui Shuguang Chemical Group

List of Tables

Table 1. Global HCN Derivate Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global HCN Derivate Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global HCN Derivate Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global HCN Derivate Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global HCN Derivate Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global HCN Derivate Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)

Table 7. Global HCN Derivate Sales by Region (2020-2025) & (Kilotons)

Table 8. Global HCN Derivate Sales by Region (2026-2031) & (Kilotons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global HCN Derivate Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)

Table 11. Global HCN Derivate Production by Region (2020-2025) & (Kilotons)

Table 12. Global HCN Derivate Production by Region (2026-2031) & (Kilotons)

Table 13. Global HCN Derivate Sales by Manufacturers (2020-2025) & (Kilotons)

Table 14. Global HCN Derivate Sales Share by Manufacturers (2020-2025)

Table 15. Global HCN Derivate Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global HCN Derivate Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global HCN Derivate by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HCN Derivate as of 2024)

Table 19. Global HCN Derivate Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global HCN Derivate Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers HCN Derivate Manufacturing Base and Headquarters

Table 22. Global HCN Derivate Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global HCN Derivate Sales by Type (2020-2025) & (Kilotons)

Table 26. Global HCN Derivate Sales by Type (2026-2031) & (Kilotons)

Table 27. Global HCN Derivate Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global HCN Derivate Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global HCN Derivate ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global HCN Derivate Sales by Application (2020-2025) & (Kilotons)

Table 32. Global HCN Derivate Sales by Application (2026-2031) & (Kilotons)

Table 33. HCN Derivate High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global HCN Derivate Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global HCN Derivate Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global HCN Derivate ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America HCN Derivate Growth Accelerators and Market Barriers

Table 40. North America HCN Derivate Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America HCN Derivate Sales (Kilotons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe HCN Derivate Growth Accelerators and Market Barriers

Table 43. Europe HCN Derivate Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe HCN Derivate Sales (Kilotons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific HCN Derivate Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific HCN Derivate Sales (Kilotons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific HCN Derivate Growth Accelerators and Market Barriers

Table 48. Southeast Asia HCN Derivate Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America HCN Derivate Investment Opportunities and Key Challenges

Table 50. Central and South America HCN Derivate Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa HCN Derivate Investment Opportunities and Key Challenges

Table 52. Middle East and Africa HCN Derivate Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Invista Corporation Information

Table 54. Invista Description and Major Businesses

Table 55. Invista Product Models, Descriptions and Specifications

Table 56. Invista Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. Invista Sales Value Proportion by Product in 2024

Table 58. Invista Sales Value Proportion by Application in 2024

Table 59. Invista Sales Value Proportion by Geographic Area in 2024

Table 60. Invista HCN Derivate SWOT Analysis

Table 61. Invista Recent Developments

Table 62. Solvay Corporation Information

Table 63. Solvay Description and Major Businesses

Table 64. Solvay Product Models, Descriptions and Specifications

Table 65. Solvay Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. Solvay Sales Value Proportion by Product in 2024

Table 67. Solvay Sales Value Proportion by Application in 2024

Table 68. Solvay Sales Value Proportion by Geographic Area in 2024

Table 69. Solvay HCN Derivate SWOT Analysis

Table 70. Solvay Recent Developments

Table 71. Evonik Corporation Information

Table 72. Evonik Description and Major Businesses

Table 73. Evonik Product Models, Descriptions and Specifications

Table 74. Evonik Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Evonik Sales Value Proportion by Product in 2024

Table 76. Evonik Sales Value Proportion by Application in 2024

Table 77. Evonik Sales Value Proportion by Geographic Area in 2024

Table 78. Evonik HCN Derivate SWOT Analysis

Table 79. Evonik Recent Developments

Table 80. Cyanco Corporation Information

Table 81. Cyanco Description and Major Businesses

Table 82. Cyanco Product Models, Descriptions and Specifications

Table 83. Cyanco Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Cyanco Sales Value Proportion by Product in 2024

Table 85. Cyanco Sales Value Proportion by Application in 2024

Table 86. Cyanco Sales Value Proportion by Geographic Area in 2024

Table 87. Cyanco HCN Derivate SWOT Analysis

Table 88. Cyanco Recent Developments

Table 89. BASF Corporation Information

Table 90. BASF Description and Major Businesses

Table 91. BASF Product Models, Descriptions and Specifications

Table 92. BASF Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. BASF Sales Value Proportion by Product in 2024

Table 94. BASF Sales Value Proportion by Application in 2024

Table 95. BASF Sales Value Proportion by Geographic Area in 2024

Table 96. BASF HCN Derivate SWOT Analysis

Table 97. BASF Recent Developments

Table 98. NOVUS Corporation Information

Table 99. NOVUS Description and Major Businesses

Table 100. NOVUS Product Models, Descriptions and Specifications

Table 101. NOVUS Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. NOVUS Recent Developments

Table 103. Orica Corporation Information

Table 104. Orica Description and Major Businesses

Table 105. Orica Product Models, Descriptions and Specifications

Table 106. Orica Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 107. Orica Recent Developments

Table 108. Chemours Corporation Information

Table 109. Chemours Description and Major Businesses

Table 110. Chemours Product Models, Descriptions and Specifications

Table 111. Chemours Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 112. Chemours Recent Developments

Table 113. Sumitomo Chemical Corporation Information

Table 114. Sumitomo Chemical Description and Major Businesses

Table 115. Sumitomo Chemical Product Models, Descriptions and Specifications

Table 116. Sumitomo Chemical Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 117. Sumitomo Chemical Recent Developments

Table 118. Ascend Performance Materials Corporation Information

Table 119. Ascend Performance Materials Description and Major Businesses

Table 120. Ascend Performance Materials Product Models, Descriptions and Specifications

Table 121. Ascend Performance Materials Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 122. Ascend Performance Materials Recent Developments

Table 123. Australian Gold Reagent Corporation Information

Table 124. Australian Gold Reagent Description and Major Businesses

Table 125. Australian Gold Reagent Product Models, Descriptions and Specifications

Table 126. Australian Gold Reagent Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 127. Australian Gold Reagent Recent Developments

Table 128. Taekwang Industrial Corporation Information

Table 129. Taekwang Industrial Description and Major Businesses

Table 130. Taekwang Industrial Product Models, Descriptions and Specifications

Table 131. Taekwang Industrial Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 132. Taekwang Industrial Recent Developments

Table 133. Asahi Kasei Corporation Corporation Information

Table 134. Asahi Kasei Corporation Description and Major Businesses

Table 135. Asahi Kasei Corporation Product Models, Descriptions and Specifications

Table 136. Asahi Kasei Corporation Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 137. Asahi Kasei Corporation Recent Developments

Table 138. Tiande Chemical Corporation Information

Table 139. Tiande Chemical Description and Major Businesses

Table 140. Tiande Chemical Product Models, Descriptions and Specifications

Table 141. Tiande Chemical Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 142. Tiande Chemical Recent Developments

Table 143. Sichuan Hebang Corporation Information

Table 144. Sichuan Hebang Description and Major Businesses

Table 145. Sichuan Hebang Product Models, Descriptions and Specifications

Table 146. Sichuan Hebang Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 147. Sichuan Hebang Recent Developments

Table 148. Hebei Chengxin Corporation Information

Table 149. Hebei Chengxin Description and Major Businesses

Table 150. Hebei Chengxin Product Models, Descriptions and Specifications

Table 151. Hebei Chengxin Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 152. Hebei Chengxin Recent Developments

Table 153. Anhui Shuguang Chemical Group Corporation Information

Table 154. Anhui Shuguang Chemical Group Description and Major Businesses

Table 155. Anhui Shuguang Chemical Group Product Models, Descriptions and Specifications

Table 156. Anhui Shuguang Chemical Group Capacity, Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 157. Anhui Shuguang Chemical Group Recent Developments

Table 158. Key Raw Materials Distribution

Table 159. Raw Materials Key Suppliers

Table 160. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 161. Milestones in Production Technology Evolution

Table 162. Distributors List

Table 163. Market Trends and Market Evolution

Table 164. Market Drivers and Opportunities

Table 165. Market Challenges, Risks, and Restraints

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. HCN Derivate Product Picture

Figure 2. Global HCN Derivate Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Sodium Cyanide Product Picture

Figure 4. Adiponitrile Product Picture

Figure 5. Methionine Product Picture

Figure 6. Others Product Picture

Figure 7. Global HCN Derivate Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Chemical Industry

Figure 9. Mining Industry

Figure 10. Pharmaceutical

Figure 11. Others

Figure 12. HCN Derivate Report Years Considered

Figure 13. Global HCN Derivate Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 15. Global HCN Derivate Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 16. Global HCN Derivate Revenue Market Share by Region (2020-2031)

Figure 17. Global HCN Derivate Sales (2020-2031) & (Kilotons)

Figure 18. Global HCN Derivate Sales (CAGR) by Region (2020-2031) (Kilotons)

Figure 19. Global HCN Derivate Sales Market Share by Region (2020-2031)

Figure 20. Global HCN Derivate Capacity, Production and Utilization (2020-2031) & (Kilotons)

Figure 21. Global HCN Derivate Production Trend by Region (2020-2031) (Kilotons)

Figure 22. Global HCN Derivate Production Market Share by Region (2020-2031)

Figure 23. Production Capacity Enablers & Constraints

Figure 24. HCN Derivate Production Growth Rate in North America (2020-2031) & (Kilotons)

Figure 25. HCN Derivate Production Growth Rate in Europe (2020-2031) & (Kilotons)

Figure 26. HCN Derivate Production Growth Rate in China (2020-2031) & (Kilotons)

Figure 27. HCN Derivate Production Growth Rate in Japan (2020-2031) & (Kilotons)

Figure 28. Top 5 and Top 10 Manufacturers HCN Derivate Sales Volume Market Share in 2024

Figure 29. Global HCN Derivate Revenue Market Share Ranking (2024)

Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 31. Sodium Cyanide Revenue Market Share by Manufacturer in 2024

Figure 32. Adiponitrile Revenue Market Share by Manufacturer in 2024

Figure 33. Methionine Revenue Market Share by Manufacturer in 2024

Figure 34. Others Revenue Market Share by Manufacturer in 2024

Figure 35. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 36. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 37. Global HCN Derivate Sales Market Share by Type (2020-2031)

Figure 38. Global HCN Derivate Revenue Market Share by Type (2020-2031)

Figure 39. Global HCN Derivate Sales Market Share by Application (2020-2031)

Figure 40. Global HCN Derivate Revenue Market Share by Application (2020-2031)

Figure 41. North America HCN Derivate Sales YoY (2020-2031) & (Kilotons)

Figure 42. North America HCN Derivate Revenue YoY (2020-2031) & (US$ Million)

Figure 43. North America Top 5 Manufacturers HCN Derivate Sales Revenue (US$ Million) in 2024

Figure 44. North America HCN Derivate Sales Volume (Kilotons) by Type (2020- 2031)

Figure 45. North America HCN Derivate Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 46. North America HCN Derivate Sales Volume (Kilotons) by Application (2020-2031)

Figure 47. North America HCN Derivate Sales Revenue (US$ Million) by Application (2020-2031)

Figure 48. US HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 49. Canada HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 50. Mexico HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 51. Europe HCN Derivate Sales YoY (2020-2031) & (Kilotons)

Figure 52. Europe HCN Derivate Revenue YoY (2020-2031) & (US$ Million)

Figure 53. Europe Top 5 Manufacturers HCN Derivate Sales Revenue (US$ Million) in 2024

Figure 54. Europe HCN Derivate Sales Volume (Kilotons) by Type (2020-2031)

Figure 55. Europe HCN Derivate Sales Revenue (US$ Million) by Type (2020-2031)

Figure 56. Europe HCN Derivate Sales Volume (Kilotons) by Application (2020-2031)

Figure 57. Europe HCN Derivate Sales Revenue (US$ Million) by Application (2020-2031)

Figure 58. Germany HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 59. France HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 60. U.K. HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 61. Italy HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 62. Russia HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 63. Asia-Pacific HCN Derivate Sales YoY (2020-2031) & (Kilotons)

Figure 64. Asia-Pacific HCN Derivate Revenue YoY (2020-2031) & (US$ Million)

Figure 65. Asia-Pacific Top 8 Manufacturers HCN Derivate Sales Revenue (US$ Million) in 2024

Figure 66. Asia-Pacific HCN Derivate Sales Volume (Kilotons) by Type (2020- 2031)

Figure 67. Asia-Pacific HCN Derivate Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 68. Asia-Pacific HCN Derivate Sales Volume (Kilotons) by Application (2020-2031)

Figure 69. Asia-Pacific HCN Derivate Sales Revenue (US$ Million) by Application (2020-2031)

Figure 70. Indonesia HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 71. Japan HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 72. South Korea HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 73. China Taiwan HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 74. India HCN Derivate Revenue (2020-2031) & (US$ Million)

Figure 75. Central and South America HCN Derivate Sales YoY (2020-2031) & (Kilotons)

Figure 76. Central and South America HCN Derivate Revenue YoY (2020-2031) & (US$ Million)

Figure 77. Central and South America Top 5 Manufacturers HCN Derivate Sales Revenue (US$ Million) in 2024

Figure 78. Central and South America HCN Derivate Sales Volume (Kilotons) by Type (2021-2031)

Figure 79. Central and South America HCN Derivate Sales Revenue (US$ Million) by Type (2020-2031)

Figure 80. Central and South America HCN Derivate Sales Volume (Kilotons) by Application (2020-2031)

Figure 81. Central and South America HCN Derivate Sales Revenue (US$ Million) by Application (2020-2031)

Figure 82. Brazil HCN Derivate Revenue (2020-2025) & (US$ Million)

Figure 83. Argentina HCN Derivate Revenue (2020-2025) & (US$ Million)

Figure 84. Middle East, and Africa HCN Derivate Sales YoY (2020-2031) & (Kilotons)

Figure 85. Middle East and Africa HCN Derivate Revenue YoY (2020-2031) & (US$ Million)

Figure 86. Middle East and Africa Top 5 Manufacturers HCN Derivate Sales Revenue (US$ Million) in 2024

Figure 87. Middle East and Africa HCN Derivate Sales Volume (Kilotons) by Type (2021-2031)

Figure 88. South America HCN Derivate Sales Revenue (US$ Million) by Type (2020-2031)

Figure 89. Middle East and Africa HCN Derivate Sales Volume (Kilotons) by Application (2020-2031)

Figure 90. Middle East and Africa HCN Derivate Sales Revenue (US$ Million) by Application (2020-2031)

Figure 91. GCC Countries HCN Derivate Revenue (2020-2025) & (US$ Million)

Figure 92. Turkey HCN Derivate Revenue (2020-2025) & (US$ Million)

Figure 93. Egypt HCN Derivate Revenue (2020-2025) & (US$ Million)

Figure 94. South Africa HCN Derivate Revenue (2020-2025) & (US$ Million)

Figure 95. HCN Derivate Industry Chain Mapping

Figure 96. Regional HCN Derivate Manufacturing Base Distribution (%)

Figure 97. HCN Derivate Production Process

Figure 98. Regional HCN Derivate Production Cost Structure

Figure 99. Channels of Distribution (Direct Vs Distribution)

Figure 100. Bottom-up and Top-down Approaches for This Report

Figure 101. Data Triangulation

Figure 102. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions